LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.20
+0.00 (+0.00%)
Open$0.05
Previous Close$0.20
Day High$0.20
Day Low$0.05
52W High$8.75
52W Low—
Volume—
Avg Volume650
Market Cap355.0K
P/E Ratio—
EPS$-19.31
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+6,900.0% upside
Current
$0.20
$0.20
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 454.7K | 684.9K | 681.7K |
| Net Income | -33,040,633 | -44,790,736 | 169.3K |
| Profit Margin | -7,266.1% | -6,902.8% | 24.8% |
| EBITDA | -34,918,989 | -49,966,922 | 337.6K |
| Free Cash Flow | — | — | 110.0K |
| Rev Growth | -33.6% | -33.6% | +3.7% |
| Debt/Equity | — | — | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |